A child with profound genetic hearing loss was dosed with an investigational otoferlin gene therapy (DB-OTO), the first patient dosed in a phase 1/2 trial evaluating the treatment. The child experienced improved auditory response at week 6 with no concerning safety signals.
Vamorolone, oral suspension 40 mg / ml, has been approved by the FDA to treat Duchenne muscular dystrophy (DMD) in patients aged 2 years and up, according to Santhera Pharmaceuticals.
Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her thoughts on the Contemporary Pediatrics' October 2023 vaccine issue.
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
In this interview with Contemporary Pediatrics®, Lauren Lanzon, MSW, MA, BCBA, clinical trainer, Carolina Behavioral Innovations, explains how technology and software is helping families following an autism diagnosis in their child.
The combination vaccine candidates demonstrated a safety profile consistent with Pfizer’s COVID-19 vaccine. A phase 3 trial is anticipated to commence in the coming months, according to a press release from Pfizer.
The Centers for Disease Control and Prevention is advising providers to prioritize 100 mg doses of nirsevimab, a monoclonal antibody FDA-approved to prevent respiratory syncytial virus (RSV), for infants at the highest risk of severe RSV disease.
Meghan Harrison, DO; and Brittany Perry, DO, discuss including early autism screening in the primary health care setting, following their session presented at the 2023 American Academy of Pediatrics National Conference & Exhibition, held in Washington DC.
While at the 2023 American Academy of Pediatrics National Conference & Exhibition, Steven Selbst, MD, spoke with Contemporary Pediatrics® about current trends in pediatric emergency medicine, and highlighted the ongoing mental health crisis.
Susan J. Kressly, MD, FAAP, shares tips and aspects of her session, "How to Ensure You Will Be Paid What You’re Worth," presented at the 2023 American Academy of Pediatrics National Conference & Exhibition, in this Contemporary Pediatrics® interview.
"I was honored this year, really truly honored, to receive the Jim Seidel Distinguished Service Award for the section of emergency medicine," said Contemporary Pediatrics Editorial Advisory Board member Steven Selbst, MD at the 2023 American Academy of Pediatrics National Conference & Exhibition.
A recent study presented at the 2023 American Academy of Pediatrics National Conference & Exhibition evaluated how clinicians can ask patients' sexual orientation and gender identity for EHR documentation.
In recent research highlighted at the 2023 American Academy of Pediatrics National Conference & Exhibition, investigators sought to evaluate the level of access and marketing of Delta-8 THC (D8) to minors online.
In this Contemporary Pediatrics interview, Michelle Loy, MD, FAAP, recaps her session, "Culinary Medicine: Using Food for Physical, Mental, and Environmental Health" presented at the 2023 American Academy of Pediatrics National Conference & Exhibition in Washington DC.
Steven Selbst, MD, provides a quick update on what he has noticed in his hospital when it comes to RSV-associated emergency department visits and how they compare to this time last year, during the "tripledemic." This interview was conducted at the 2023 American Academy of Pediatrics National Conference and Exhibition in Washington DC.
In this Contemporary Pediatrics® interview, Scott Sicherer, MD, FAAP, discusses his session, "Feed the Baby! Essential Advice for Food Introduction and Allergy Prevention," presented at the 2023 2023 American Academy of Pediatrics National Conference & Exhibition.
At the 2023 American Academy of Pediatrics National Conference & Exhibition, Eric J. Sigel, MD, FAAP, professor of pediatrics, University of Colorado School of Medicine, explains his session "Suicide and Gun Violence: What We Know, What We Can Do."
Leah K. Middleberg, MD, FAAP, explains her research on magnet ingestion and socioeconomic disparities, which was recently presented at the 2023 American Academy of Pediatrics National Conference & Exhibition.
At the 2023 American Academy of Pediatrics National Conference & Exhibition, Paul V. Williams, MD, FAAP, explains his session "Tell Me it Ain't So: Delabeling Penicillin Allergy," and how general pediatricians can make a difference by removing a false penicillin allergy label from a child's medical record.
A recent study was highlighted at the 2023 American Academy of Pediatrics National Conference & Exhibition that shed light on the long-term impact of very preterm birth on the health-related quality of life (HRQOL) of infants and identified key determinants.
George J. Fuchs, III, MD, FAAP, explains how certain branding and labeling can lead parents to purchase toddler formula, though products are not nutritionally complete and lack FDA regulations present in infant formulas. This interview was conducted at the 2023 American Academy of Pediatrics National Conference & Exhibition in Washington DC.
Eculizumab and anakinra should be considered in critically ill patients with severe infections that require immunomodulating therapies for life-threatening dysregulation, according to a poster session at the 2023 American Academy of Pediatrics National Conference & Exhibition.
The Complete Response Letter (CRL) is based on additional efficacy data required by the FDA, according to Sanofi and Regeneron.
The topical gel is the first and only FDA-approved triple-combination, fixed-dose topical treatment for acne, and is set to be available in the first quarter of 2024, according to Bausch Health Companies Inc.
Nipocalimab (Janssen) may be promising for the antenatal and postnatal management of fetal anemia in pregnancies at high risk for EOS-HDFN , according to data from the phase 2 UNITY study presented at the 2023 American Academy of Pediatrics National Conference & Exhibition
In a phase 2 clinical trial, the safety and efficacy of vosoritide was similar in children aged younger than 5 years to those older than 5 years.
The FDA approval could simplify meningococcal vaccine schedules while providing broad serogroup coverage.
Authors of a study highlighted at the 2023 American Academy of Pediatrics National Conference & Exhibition suggest psychosocial factors are significant contributors to parents' decisions regarding safe sleep
A new study says yes.
A new study suggests that new information on who is most likely to have a reaction may help boost immunizations.
